Lung Cancerby Jack A. Roth, James D. Cox, Waun Ki Hong
- LendMe LendMe™ Learn More
Lung cancer is a major cause of cancer-related deaths in men and women. However, since the first edition of Lung Cancer was published 14 years ago, rapid progress in the biology, prevention, diagnosis, and treatment of the disease has been made.
Description: This is the third edition of a book that broadly addresses all aspects of lung cancer, including epidemiology, biology, and diagnosis, with special emphasis on recent advances in management occurring during the past decade. It is significantly revised from the first edition published 10-14 years earlier (in 1998, according to publisher's data; in 1994, according to the editors' preface). The compilation was edited by three well known academicians at the University of Texas M. D. Anderson Cancer Center Jack A. Roth, MD, James D. Cox, MD, and Waun Ki Hong, MD), with over 60 contributors of international renown.
Purpose: In aggregate, an attempt is made to adopt the observations of authorities from diverse experience, providing a comprehensive review of the current state of the art on bronchogenic carcinoma.
Audience: The audience would include primarily pulmonologists, thoracic surgeons, oncologists, or those aspiring to these disciplines. Others would undoubtedly find the reference selectively informative. It would additionally provide a real-life reference for basic science researchers in putting a face on applications carried out in the laboratory.
Features: The book covers the broad subject of bronchogenic carcinoma and augments substantially the presentation of the last edition. Although usually sufficient to carry out the ends of each chapter, the illustrations and graphics are quite limited and probably represent the most notable shortcoming of the book. The bibliographies at each chapter end are extensive and relevant.
Assessment: The is one of the most comprehensive and up-to-date treatises that I have surveyed, yet it is remarkably simple and to the point, covering basic molecular biology and genetics underlying the disease for the clinician, as well as epidemiology, early diagnosis, clinical presentation, and management. It focuses exceptionally upon the speculated growing role for targeted therapies with more limited toxicities than historical treatments. The book achieves its likely intended goals well. For an average practitioner, it comes across as very reachable, but probably not a compelling read. I would recommend the book highly to anyone in allied disciplines, and would personally consider it a practical resource to add to my personal library.
- Publication date:
- Sold by:
- Barnes & Noble
- NOOK Book
- File size:
- 6 MB
What People are Saying About This
“One of the most comprehensive and up-to-date treatises that I have surveyed … .I would recommend the book highly to anyone in allied disciplines.” (Doody's Book Reviews)
Meet the Author
Jack A. Roth, MD FACS, Professor and Chairman, Bud Johnson Clinical Distinguished Chair, The University of Texas M.D. Anderson Cancer Center, Department of Thoracic&Cardiovascular Surgery and Professor of Molecular and Cellular Oncology, Director, W.M. Keck Center for Cancer Gene Therapy, Houston, Texas, USA.
James D. Cox, MD, Professor and Head, Division of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Waun Ki Hong, MD, American Cancer Society Clinical Research Professor, Charles A. LeMistre Distinguished Chair in Thoracic Oncology and Professor and Chairman, Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Most Helpful Customer Reviews
See all customer reviews